Categories AlphaGraphs, Earnings, Health Care
Earnings: Highlights of Thermo Fisher Scientific’s (TMO) Q1 2025 report
Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday announced financial results for the first quarter of 2025, reporting a modest increase in adjusted earnings.
First-quarter revenue was $10.4 billion, which is broadly unchanged from the comparable quarter of 2024. Weakness in the core Laboratory Products & Services segment offset revenue growth in the other division.
On an adjusted basis, Q1 earnings edged up to $5.15 per share from $5.11 per share in the year-ago quarter. Net income, on a reported basis, increased to $1.51 billion or $3.98 per share in the March quarter from $1.33 billion or $3.46 per share a year earlier.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Lamb Weston (LW) Q2 2026 Earnings: Key financials and quarterly highlights
Lamb Weston Holdings, Inc. (NYSE: LW) reported its second quarter 2026 earnings results today. Net sales inched up 1% year-over-year to $1.62 billion. Net sales at constant currency remained flat.
Paychex reports higher Q2 FY26 revenue and earnings; EPS beats estimates
Paychex Inc. (NASDAQ: PAYX) on Friday reported stronger-than-expected adjusted earnings for the second quarter of fiscal 2026. Revenues grew 18% year-over-year. The Rochester-based human capital management solutions provider reported revenues
Key highlights from NIKE’s (NKE) Q2 2026 earnings results
NIKE, Inc. (NYSE: NKE) reported revenues of $12.4 billion for the second quarter of 2026, which were up 1% on a reported basis and flat on a currency-neutral basis compared
